Marijuana and cannabinoid regulation of brain reward circuits

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011 · see citing works

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.

Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733 · see citing works

Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: Resistance to differential rearing conditions

Bardo, M. T., & Hammer, R. P. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90226-e · Cited by 3,229 · see citing works

A psychomotor stimulant theory of addiction.

Wise, R. A., & Bozarth, M. A. (1987) · Psychological Review · doi:10.1037/0033-295x.94.4.469 · Cited by 2,747 · see citing works

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389 · see citing works

Cannabinoid receptor localization in brain.

Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321 · see citing works

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159 · see citing works

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

Rinaldi, M. L., Barth, F., Héaulme, M., Shire, D. J., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,751 · see citing works

Opioids excite dopamine neurons by hyperpolarization of local interneurons

Johnson, S., & North, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00483.1992 · Cited by 1,637 · see citing works

Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses

Wilson, R. I., & Nicoll, R. A. (2001) · Nature · doi:10.1038/35069076 · Cited by 1,607 · see citing works

Role of Endogenous Cannabinoids in Synaptic Signaling

Freund, T. F., Katona, I., & Piomelli, D. (2003) · Physiological Reviews · doi:10.1152/physrev.00004.2003 · Cited by 1,567 · see citing works

Pharmacology of cannabinoid CB1 and CB2 receptors

Pertwee, R. G. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)82001-3 · Cited by 1,489 · see citing works

Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

Bisogno, T., Hanuš, L., PETROCELLIS, L. D., Tchilibon, S., Ponde, D. E., Brandi, I., Moriello, A. S., Davis, J. B., Mechoulam, R., & Marzo, V. D. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704327 · Cited by 1,315 · see citing works

Endocannabinoid Signaling in the Brain

Wilson, R. I., & Nicoll, R. A. (2002) · Science · doi:10.1126/science.1063545 · Cited by 1,260 · see citing works

Specificity in the projection patterns of accumbal core and shell in the rat

Heimer, L., Zahm, D. S., Churchill, L., Kalivas, P. W., & Wohltmann, C. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90202-y · Cited by 1,219 · see citing works

Drugs of Abuse and Stress Trigger a Common Synaptic Adaptation in Dopamine Neurons

Saal, D., Dong, Y., Bonci, A., & Malenka, R. C. (2003) · Neuron · doi:10.1016/s0896-6273(03)00021-7 · Cited by 1,147 · see citing works

Cannabinoid and Heroin Activation of Mesolimbic Dopamine Transmission by a Common µ 1 Opioid Receptor Mechanism

Tanda, G., Pontieri, F. E., & Chiara, G. D. (1997) · Science · doi:10.1126/science.276.5321.2048 · Cited by 1,079 · see citing works

Inhibitory control of neostriatal projection neurons by GABAergic interneurons

Koós, T. Z., & Tepper, J. M. (1999) · Nature Neuroscience · doi:10.1038/8138 · Cited by 851 · see citing works

Addictive Drugs and Brain Stimulation Reward

Wise, R. A. (1996) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.19.030196.001535 · Cited by 792 · see citing works

Postsynaptic endocannabinoid release is critical to long-term depression in the striatum

Gerdeman, G. L., Ronesi, J. A., & Lovinger, D. M. (2002) · Nature Neuroscience · doi:10.1038/nn832 · Cited by 767 · see citing works

Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry

Gonon, F. G. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90307-7 · Cited by 676 · see citing works

Modulation of transmitter release via presynaptic cannabinoid receptors

Schlicker, E., & Kathmann, M. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01805-8 · Cited by 671 · see citing works

Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens

Robbe, D., Köpf, M., Rémaury, A., Bockaert, J., & Manzoni, O. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122149199 · Cited by 631 · see citing works

Localization of cannabinoid receptor mRNA in rat brain

Matsuda, L. A., Bonner, T. I., & Lolait, S. J. (1993) · Journal of Comparative Neurology · doi:10.1002/cne.903270406 · Cited by 631 · see citing works

Long-term depression in the nucleus accumbens: a neural correlate of behavioral sensitization to cocaine

Thomas, M. J., Beurrier, C., Bonci, A., & Malenka, R. C. (2001) · Nature Neuroscience · doi:10.1038/nn757 · Cited by 629 · see citing works

Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids

Alger, B. E. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00080-1 · Cited by 599 · see citing works

Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies

McBride, W. J., Murphy, J. M., & Ikemoto, S. (1999) · Behavioural Brain Research · doi:10.1016/s0166-4328(99)00022-4 · Cited by 574 · see citing works

Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons

Twitchell, W., Brown, S., & Mackie, K. (1997) · Journal of Neurophysiology · doi:10.1152/jn.1997.78.1.43 · Cited by 544 · see citing works

Evidence for a New G Protein-Coupled Cannabinoid Receptor in Mouse Brain

Breivogel, C. S., Griffin, G., Marzo, V. D., & Martin, B. R. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.1.155 · Cited by 537 · see citing works

An integrative neuroanatomical perspective on some subcortical substrates of adaptive responding with emphasis on the nucleus accumbens

Zahm, D. S. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(99)00065-2 · Cited by 487 · see citing works

It could be habit forming: drugs of abuse and striatal synaptic plasticity

Gerdeman, G. L., Partridge, J. G., Lupica, C. R., & Lovinger, D. M. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00065-1 · Cited by 480 · see citing works

Blockade of Effects of Smoked Marijuana by the CB1-Selective Cannabinoid Receptor Antagonist SR141716

Huestis, M. A., Gorelick, D. A., Heishman, S. J., Preston, K. L., Nelson, R. A., Moolchan, E. T., & Frank, R. A. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.4.322 · Cited by 479 · see citing works

Endocannabinoids Mediate Presynaptic Inhibition of Glutamatergic Transmission in Rat Ventral Tegmental Area Dopamine Neurons through Activation of CB1 Receptors

Melis, M., Pistis, M., Perra, S., Muntoni, A. L., Pillolla, G., & Gessa, G. L. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4503-03.2004 · Cited by 478 · see citing works

Endocannabinoids

Mechoulam, R., Fride, E., & Marzo, V. D. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00649-9 · Cited by 431 · see citing works

Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus

Hájos, N., Ledent, C. A., & Freund, T. F. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00287-1 · Cited by 420 · see citing works

Burst Firing in Dopamine Neurons Induced by N -Methyl-D-aspartate: Role of Electrogenic Sodium Pump

Johnson, S. W., Seutin, V., & North, R. A. (1992) · Science · doi:10.1126/science.1329209 · Cited by 419 · see citing works

Mechanisms of Cannabinoid Inhibition of GABAASynaptic Transmission in the Hippocampus

Hoffman, A. F., & Lupica, C. R. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-07-02470.2000 · Cited by 401 · see citing works

Being stoned: a review of self‐reported cannabis effects

Green, B., Kavanagh, D. J., & Young, R. M. (2003) · Drug and Alcohol Review · doi:10.1080/09595230310001613976 · Cited by 390 · see citing works

Electrophysiological Characterization of GABAergic Neurons in the Ventral Tegmental Area

Steffensen, S. C., Svingos, A. L., Pickel, V. M., & Henriksen, S. J. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-19-08003.1998 · Cited by 388 · see citing works

Neuropharmacological Mechanisms of Drug Reward: Beyond Dopamine in the Nucleus Accumbens

Bardo, M. T. (1998) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v12.i1-2.30 · Cited by 383 · see citing works

Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra

French, E. D., Dillon, K. A., & Wu, X. (1997) · Neuroreport · doi:10.1097/00001756-199702100-00014 · Cited by 374 · see citing works

Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors

Gessa, G., Melis, M., Muntoni, A., & Diana, M. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01442-8 · Cited by 370 · see citing works

Localization and Mechanisms of Action of Cannabinoid Receptors at the Glutamatergic Synapses of the Mouse Nucleus Accumbens

Robbe, D., Alonso, G., Duchamp, F., Bockaert, J., & Manzoni, O. J. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-01-00109.2001 · Cited by 367 · see citing works

Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys

Tanda, G., Munzar, P., & Goldberg, S. R. (2000) · Nature Neuroscience · doi:10.1038/80577 · Cited by 347 · see citing works

Δ9-Tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis

Chen, J., Paredes, W. M., Li, J., Smith, D. M., Lowinson, J. H., & Gardner, E. L. (1990) · Psychopharmacology · doi:10.1007/bf02245916 · Cited by 329 · see citing works

GABA-containing neurons in the ventral tegmental area project to the nucleus accumbens in rat brain

Bockstaele, E. J. V., & Pickel, V. M. (1995) · Brain Research · doi:10.1016/0006-8993(95)00334-m · Cited by 328 · see citing works

Rewarding Actions of Phencyclidine and Related Drugs in Nucleus Accumbens Shell and Frontal Cortex

Carlezon, & Wise, R. A. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-09-03112.1996 · Cited by 327 · see citing works

Cannabinoids: reward, dependence, and underlying neurochemical mechanisms?a review of recent preclinical data

Tanda, G., & Goldberg, S. R. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1485-z · Cited by 280 · see citing works

SHORT COMMUNICATION Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids

Szabó, B., Siemes, S., & Wallmichrath, I. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02041.x · Cited by 277 · see citing works

Brain reward circuitry: Four circuit elements “wired” in apparent series

Wise, R. A., & Bozarth, M. A. (1984) · Brain Research Bulletin · doi:10.1016/0361-9230(84)90190-4 · Cited by 252 · see citing works

Cannabinoid Transmission and Reward-Related Events

Gardner, E. L., & Vorel, S. R. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0219 · Cited by 247 · see citing works

When inhibition goes incognito: feedback interaction between spiny projection neurons in striatal function

Plenz, D. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00196-6 · Cited by 242 · see citing works

Cannabinoid receptors in microglia of the central nervous system: immune functional relevance

Cabral, G. A., & Marciano‐Cabral, F. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0405216 · Cited by 240 · see citing works

Δ9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors

French, E. D. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00278-4 · Cited by 236 · see citing works

Biochemical evidence for γ-aminobutyrate containing fibres from the nucleus accumbens to the substantia nigra and ventral tegmental area in the rat

Walaas, I., & Fonnum, F. (1980) · Neuroscience · doi:10.1016/0306-4522(80)90071-8 · Cited by 235 · see citing works

Afferent modulation of dopamine neuron firing patterns

Kitai, S. T., Shepard, P. D., Callaway, J. C., & Scroggs, R. S. (1999) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(99)00040-9 · Cited by 234 · see citing works

Cannabinoids, hippocampal function and memory

Hampson, R. E., & Deadwyler, S. A. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00294-5 · Cited by 221 · see citing works

Synaptic inputs to GABAA and GABAB receptors originate from discrete afferent neurons

Sugita, S., Johnson, S. W., & North, R. A. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90518-c · Cited by 220 · see citing works

A single in-vivo exposure to Δ9THC blocks endocannabinoid-mediated synaptic plasticity

Mato, S., Chevaleyre, V., Robbe, D., Pazos, Á., Castillo, P. E., & Manzoni, O. J. (2004) · Nature Neuroscience · doi:10.1038/nn1251 · Cited by 220 · see citing works

Cannabinoid Receptors and Modulation of Cyclic AMP Accumulation in the Rat Brain

Bidaut‐Russell, M., Devane, W. A., & Howlett, A. C. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb08815.x · Cited by 208 · see citing works

Brain mechanisms of drug reward and euphoria.

Wise, R. A., & Bozarth, M. A. (1985) · PubMed · Cited by 206 · see citing works

Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers

Hájos, N., & Freund, T. F. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00157-0 · Cited by 198 · see citing works

Marijuana's interaction with brain reward systems: Update 1991

Gardner, E. L., & Lowinson, J. H. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90365-9 · Cited by 197 · see citing works

A Postsynaptic Interaction between Dopamine D1and NMDA Receptors Promotes Presynaptic Inhibition in the Rat Nucleus Accumbens via Adenosine Release

Harvey, J., & Lacey, M. G. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-14-05271.1997 · Cited by 196 · see citing works

Direct Actions of Cannabinoids on Synaptic Transmission in the Nucleus Accumbens: A Comparison With Opioids

Hoffman, A. F., & Lupica, C. R. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.85.1.72 · Cited by 194 · see citing works

Functional Tolerance and Blockade of Long-Term Depression at Synapses in the Nucleus Accumbens after Chronic Cannabinoid Exposure

Hoffman, A. F., Oz, M., Caulder, T., & Lupica, C. R. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-12-04815.2003 · Cited by 193 · see citing works

Cellular and Molecular Mechanisms Underlying Learning and Memory Impairments Produced by Cannabinoids: Figure 1.Preprint

Sullivan, J. (2000) · Learning & Memory · doi:10.1101/lm.7.3.132 · Cited by 173 · see citing works

Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes

Henry, D. J., & Chavkin, C. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11289-9 · Cited by 172 · see citing works

A subset of ventral tegmental area neurons is inhibited by dopamine, 5-hydroxytryptamine and opioids

Cameron, D., Wessendorf, M. W., & Williams, J. T. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00444-7 · Cited by 163 · see citing works

Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids

Diana, M., Melis, M., & Gessa, G. L. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00292.x · Cited by 152 · see citing works

The effects of Δ9-tetrahydrocannabinol on potassium-evoked release of dopamine in the rat caudate nucleus: an in vivo electrochemical and in vivo microdialysis study

Ton, J. M. N. C., Gerhardt, G. A., Friedemann, M., Etgen, A. M., Rose, G., Sharpless, N. S., & Gardner, E. L. (1988) · Brain Research · doi:10.1016/0006-8993(88)90749-4 · Cited by 140 · see citing works

Addictive potential of cannabinoids: the underlying neurobiology

Gardner, E. L. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00162-7 · Cited by 137 · see citing works

Increase in meso‐prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids

Diana, M., Melis, M., & Gessa, G. L. (1998) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1998.00292.x · Cited by 129 · see citing works

μ-Opioid Receptors Modulate NMDA Receptor-Mediated Responses in Nucleus Accumbens Neurons

Martin, G. E., Nie, Z., & Siggins, G. R. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-01-00011.1997 · Cited by 127 · see citing works

Modulation of Synaptic Transmission by Dopamine and Norepinephrine in Ventral but not Dorsal Striatum

Nicola, S. M., & Malenka, R. C. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.79.4.1768 · Cited by 123 · see citing works

Microinjections of phencyclidine (PCP) and related drugs into nucleus accumbens shell potentiate medial forebrain bundle brain stimulation reward

Carlezon, W. A., Wise, R. A., & Carlezon, W. A. (1996) · Psychopharmacology · doi:10.1007/s002130050151 · Cited by 119 · see citing works

Effects of chronic Δ9-tetrahydrocannabinol on rat midbrain dopamine neurons: an electrophysiological assessment

Wu, X., & French, E. D. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00140-9 · Cited by 116 · see citing works

Increased Opioid Inhibition of GABA Release in Nucleus Accumbens during Morphine Withdrawal

Chieng, B. C. H., & Williams, J. T. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-17-07033.1998 · Cited by 112 · see citing works

Cannabinoids inhibit GABAergic synaptic transmission in mice nucleus accumbens

Manzoni, O. J., & Bockaert, J. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00723-3 · Cited by 103 · see citing works

Ventral tegmental microinjection of Δ9-tetrahydrocannabinol enhances ventral tegmental somatodendritic dopamine levels but not forebrain dopamine levels: evidence for local neural action by marijuana's psychoactive ingredient

Chen, J., Marmur, R., Pulles, A., Paredes, W. M., & Gardner, E. L. (1993) · Brain Research · doi:10.1016/0006-8993(93)90298-2 · Cited by 93 · see citing works

Functional localization of cannabinoid receptors and endogenous cannabinoid production in distinct neuron populations of the hippocampus

Hoffman, A. F., Riegel, A. C., & Lupica, C. R. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02773.x · Cited by 80 · see citing works

Lack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study

Cheer, J. F., Marsden, C. A., Kendall, D. A., & Mason, R. J. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00241-4 · Cited by 77 · see citing works

Effect of amphetamine on extrastriatal D2 dopamine receptor binding in the primate brain: A PET study

Chou, Y.-H., Halldin, C., & Farde, L. (2000) · Synapse · doi:10.1002/1098-2396(200011)38:2 · Cited by 57 · see citing works

Dopamine D1 and D2 receptors in the forebrain of Dystonia musculorum mutant mice: An autoradiographic survey in relation to dopamine contents

Ongali, B., Ase, A. R., H�bert, C., Amdiss, F., & Reader, T. A. (2000) · Synapse · doi:10.1002/(sici)1098-2396(200007)37:1 · Cited by 21 · see citing works

The effects of delta-9-THC on mechanisms of learning and memory.

Deadwyler, S. A., Heyser, C. J., Michaelis, R. C., & Hampson, R. E. (1990) · PubMed · Cited by 14 · see citing works

The Endocannabinoid System as an Emerging Target of Pharmacotherapy

Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077 · see citing works

Dopamine reward circuitry: Two projection systems from the ventral midbrain to the nucleus accumbens–olfactory tubercle complex

Ikemoto, S. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.05.004 · Cited by 1,477 · see citing works

REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade

Tzschentke, T. M. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00070.x · Cited by 1,336 · see citing works

ENDOCANNABINOID-MEDIATED SYNAPTIC PLASTICITY IN THE CNS

Chevaleyre, V., Takahashi, K. A., & Castillo, P. E. (2006) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.112834 · Cited by 779 · see citing works

Adult ADHD and comorbid disorders: clinical implications of a dimensional approach

Katzman, M. A., Bilkey, T. S., Chokka, P. R., Fallu, A., & Klassen, L. J. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1463-3 · Cited by 732 · see citing works

Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: Results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

Lopez‐Quintero, C., Cobos, J. P. D. L., Hasin, D. S., Okuda, M., Wang, S., Grant, B. F., & Blanco, C. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.11.004 · Cited by 702 · see citing works

The mesolimbic dopamine system: The final common pathway for the reinforcing effect of drugs of abuse?

Pierce, R. C., & Kumaresan, V. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.04.016 · Cited by 913 · see citing works

CANNABINOID RECEPTORS AS THERAPEUTIC TARGETS

Mackie, K. (2005) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141254 · Cited by 508 · see citing works

Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum

Bossong, M., van Berckel, B. N., Boellaard, R., Zuurman, L., Schuit, R., Windhorst, A., van Gerven, J. V., Ramsey, N., Lammertsma, A., & Kahn, R. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.138 · Cited by 262 · see citing works

Endocannabinoid signaling system and brain reward: emphasis on dopamine

GARDNER, E. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.032 · Cited by 387 · see citing works

Male Sexual Behavior

Hull, E. M., & Rodrı́guez–Manzo, G. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00001-2 · Cited by 371 · see citing works

One Is Not Enough: Understanding and Modeling Polysubstance Use

Crummy, E. A., O’Neal, T. J., Baskin, B. M., & Ferguson, S. M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00569 · Cited by 351 · see citing works

Blurred Boundaries: The Therapeutics and Politics of Medical Marijuana

Bostwick, J. M. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2011.10.003 · Cited by 261 · see citing works

Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction

Lupica, C. R., & Riegel, A. C. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.03.016 · Cited by 256 · see citing works

Cannabis use is quantitatively associated with nucleus accumbens and amygdala abnormalities in young adult recreational users

Gilman, J. M., Kuster, J. K., Lee, S., Lee, M. J., Kim, B. W., Makris, N., van der Kouwe, A., Blood, A. J., & Breiter, H. C. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.4745-13.2014 · Cited by 250 · see citing works

The endocannabinoid system in brain reward processes

Solinas, M., Goldberg, S. R., & Piomelli, D. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.130 · Cited by 243 · see citing works

Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice

Rademacher, D. J., Meier, S. E., Shi, L., Vanessa Ho, W.-S., Jarrahian, A., & Hillard, C. J. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.06.012 · Cited by 233 · see citing works

WIN55,212‐2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mouse model of Parkinson’s disease

Price, D. A., Martinez, A. A., Seillier, A., Koek, W., Acosta, Y. P. V., Fernández, E., Strong, R., Lutz, B., Marsicano, G., Roberts, J. L., et al. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06764.x · Cited by 231 · see citing works

The endocannabinoid system: emotion, learning and addiction

Moreira, F. A., & Lutz, B. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00104.x · Cited by 222 · see citing works

Endocannabinoids in the regulation of appetite and body weight

Kirkham, T. C. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00004 · Cited by 220 · see citing works

Lack of CB1 Cannabinoid Receptor Impairs Cocaine Self-Administration

Sòria, G., Mendizábal, V. E., Touriño, C., Robledo, P., Ledent, C. A., Parmentier, M., Maldonado, R. J., & Valverde, O. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300707 · Cited by 214 · see citing works

A new control center for dopaminergic systems: pulling the VTA by the tail

Bourdy, R., & Barrot, M. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.06.007 · Cited by 208 · see citing works

The Role of cannabinoids in neuroanatomic alterations in cannabis users.

Lorenzetti, V., Solowij, N., & Yücel, M. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.11.013 · Cited by 208 · see citing works

A review of co‐morbid tobacco and cannabis use disorders: Possible mechanisms to explain high rates of co‐use

Rabin, R. A., & George, T. P. (2015) · American Journal on Addictions · doi:10.1111/ajad.12186 · Cited by 206 · see citing works

Progress in brain cannabinoid CB2 receptor research: From genes to behavior

Jordan, C. J., & Xi, Z. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.12.026 · Cited by 197 · see citing works

Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression?

Hill, M. N., & Gorzalka, B. B. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00006 · Cited by 193 · see citing works

Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area

Mátyás, F., Urbán, G. M., Watanabe, M., Mackie, K., Zimmer, A., Freund, T. F., & Katona, I. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.05.028 · Cited by 187 · see citing works

Dopamine release is heterogeneous within microenvironments of the rat nucleus accumbens

Wightman, R. M., Heien, M. L., Wassum, K. M., Sombers, L. A., Aragona, B. J., Khan, A. S., Ariansen, J. L., Cheer, J. F., Phillips, P. E. M., & Carelli, R. M. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05772.x · Cited by 179 · see citing works

Chronic effects of cannabis use on the human reward system: An fMRI study

van Hell, H. H., Vink, M., Ossewaarde, L., Jager, G., Kahn, R. S., & Ramsey, N. F. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.11.010 · Cited by 175 · see citing works

Two brain sites for cannabinoid reward

Zangen, A., Solinas, M., Ikemoto, S., Goldberg, S. R., & Wise, R. A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3554-05.2006 · Cited by 174 · see citing works

Receptor-independent actions of cannabinoids on cell membranes: Focus on endocannabinoids

Öz, M. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.09.009 · Cited by 164 · see citing works

Cannabinoid–Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders

Fernández‐Ruíz, J., Hernández, M., & Ramos, J. A. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00144.x · Cited by 163 · see citing works

Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c‐Fos expression in the hypothalamus

Gómez, E. S., Matias, I., Rueda‐Orozco, P. E., Cisneros, M., Petrosino, S., Navarro, L., Marzo, V. D., & Prospero-Garcia, O. E. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707313 · Cited by 158 · see citing works

Disruption of PTEN coupling with 5-HT2C receptors suppresses behavioral responses induced by drugs of abuse

Ji, S., Zhang, Y., Cleemput, J. V., Jiang, W., Liao, M., Li, L., Wan, Q., Backstrom, J. R., & Zhang, X. (2006) · Nature Medicine · doi:10.1038/nm1349 · Cited by 156 · see citing works

A role for cannabinoid CB1 receptors in mood and anxiety disorders

Witkin, J. M., Tzavara, E. T., & Nomikos, G. G. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00005 · Cited by 156 · see citing works

The endocannabinoid system and psychiatric disorders

Parolaro, D., Realini, N., Viganò, D., Guidali, C., & Rubino, T. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.03.018 · Cited by 150 · see citing works

Microbiota‐gut‐brain axis as a regulator of reward processes

García‐Cabrerizo, R., Carbia, C., O’Riordan, K. J., Schellekens, H., & Cryan, J. F. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15284 · Cited by 147 · see citing works

Deficits in striatal dopamine release in cannabis dependence

van de Giessen, E., Weinstein, J. J., Cassidy, C., Haney, M., Dong, Z., Ghazzaoui, R., Ojeil, N., Kegeles, L. S., Xu, X., Vadhan, N. P., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.21 · Cited by 136 · see citing works

Self-administration of cannabinoids by experimental animals and human marijuana smokers

Justinová, Z., Goldberg, S. R., Heishman, S. J., & Tanda, G. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.026 · Cited by 137 · see citing works

Cannabis and the developing brain: Insights from behavior

Trezza, V., Cuomo, V., & Vanderschuren, L. J. M. J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.058 · Cited by 131 · see citing works

The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction

López‐Moreno, J. A., González‐Cuevas, G., Moreno, G., & Navarro, M. A. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00105.x · Cited by 131 · see citing works

Cannabinoid mechanism in reinstatement of heroin‐seeking after a long period of abstinence in rats

Fattore, L., Spano, M. S., Cossu, G., Deiana, S., & Fratta, W. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02607.x · Cited by 128 · see citing works

The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder

Chye, Y., Christensen, E., Solowij, N., & Yücel, M. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00063 · Cited by 128 · see citing works

The role of corticotropin-releasing factor-like peptides in cannabis, nicotine, and alcohol dependence

Bruijnzeel, A. W., & Gold, M. S. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.01.007 · Cited by 125 · see citing works

Decreased Cocaine Motor Sensitization and Self-Administration in Mice Overexpressing Cannabinoid CB2 Receptors

Aracil-Fernández, A., Trigo, J. M., García‐Gutiérrez, M. S., Ortega-Álvaro, A., Ternianov, A., Navarro, D., Robledo, P., Berbel, P. J., Maldonado, R. J., & Manzanares, J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.22 · Cited by 119 · see citing works

Cannabinoid CB1receptor‐interacting proteins: novel targets for central nervous system drug discovery?

Smith, T. H., Sim‐Selley, L. J., & Selley, D. E. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00777.x · Cited by 117 · see citing works

Cannabinoid CB1 Receptor Antagonists Attenuate Cocaine's Rewarding Effects: Experiments with Self-Administration and Brain-Stimulation Reward in Rats

Xi, Z., Spiller, K. J., Pak, A. C., Gilbert, J. G., Dillon, C., Li, X., Peng, X., & Gardner, E. L. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301552 · Cited by 115 · see citing works

Cannabinoid self-administration increases dopamine release in the nucleus accumbens

Fadda, P., Scherma, M., Spano, M. S., Salis, P., Melis, V., Fattore, L., & Fratta, W. (2006) · Neuroreport · doi:10.1097/01.wnr.0000236853.40221.8e · Cited by 114 · see citing works

Mechanisms of CB1 receptor signaling: endocannabinoid modulation of synaptic strength

Mackie, K. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803273 · Cited by 114 · see citing works

Opioid Antagonism of Cannabinoid Effects: Differences between Marijuana Smokers and Nonmarijuana Smokers

Haney, M. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301243 · Cited by 113 · see citing works

Endocannabinoid Actions on Cortical Terminals Orchestrate Local Modulation of Dopamine Release in the Nucleus Accumbens

Mateo, Y., Johnson, K. A., Covey, D. P., Atwood, B. K., Wang, H., Zhang, S., Gildish, I., Cachope, R., Bellocchio, L., Guzmán, M., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.11.012 · Cited by 108 · see citing works

Molecular mechanisms of maternal cannabis and cigarette use on human neurodevelopment

Morris, C. V., DiNieri, J. A., Szutorisz, H., & Hurd, Y. L. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07884.x · Cited by 111 · see citing works

Cannabis in Sport

Huestis, M. A., Mazzoni, I. E., & Rabin, O. (2011) · Sports Medicine · doi:10.2165/11591430-000000000-00000 · Cited by 110 · see citing works

A Role for the Endocannabinoid System in the Increased Motivation for Cocaine in Extended-Access Conditions

Orío, L., Edwards, S., George, O., Parsons, L. H., & Koob, G. F. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0563-09.2009 · Cited by 109 · see citing works

Blocking cannabinoid CB1receptors for the treatment of nicotine dependence: insights from pre‐clinical and clinical studies

Foll, B. L., Forget, B., Aubin, H., & Goldberg, S. R. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00113.x · Cited by 106 · see citing works

Dual Roles of Dopamine in Food and Drug Seeking: The Drive-Reward Paradox

Wise, R. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.001 · Cited by 95 · see citing works

Cocaine-Induced Endocannabinoid Mobilization in the Ventral Tegmental Area

Wang, H., Treadway, T., Covey, D. P., Cheer, J. F., & Lupica, C. R. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.041 · Cited by 95 · see citing works

Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine

Viganò, D., Valenti, M., Cascio, M. G., Marzo, V. D., Parolaro, D., & Rubino, T. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03645.x · Cited by 97 · see citing works

CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid‐seeking behaviour in the rat

Spano, M. S., Fattore, L., Cossu, G., Deiana, S., Fadda, P., & Fratta, W. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705932 · Cited by 95 · see citing works

Reduced expression of glutamate receptors and phosphorylation of CREB are responsible for in vivoΔ9‐THC exposure‐impaired hippocampal synaptic plasticity

Fan, N., Yang, H., Zhang, J., & Chen, C. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06489.x · Cited by 93 · see citing works

The role of CB1 receptors in psychostimulant addiction

Wiskerke, J., Pattij, T., Schoffelmeer, A. N. M., & Vries, T. J. D. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00109.x · Cited by 91 · see citing works

Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking

Gamaleddin, I., Wertheim, C. E., Zhu, A. Z. X., Coen, K. M., Vemuri, K. V., Makryannis, A., Goldberg, S. R., & Foll, B. L. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00314.x · Cited by 92 · see citing works

Cannabinoid receptor CNR1 expression and DNA methylation in human prefrontal cortex, hippocampus and caudate in brain development and schizophrenia

Tao, R., Li, C., Jaffe, A. E., Shin, J. H., Deep‐Soboslay, A., Yamin, R., Weinberger, D. R., Hyde, T. M., & Kleinman, J. E. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0832-8 · Cited by 88 · see citing works

Drug-induced Alterations in the Extracellular Signal-regulated Kinase (ERK) Signalling Pathway: Implications for Reinforcement and Reinstatement

Zhai, H., Li, Y., Wang, X., & Lü, L. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9240-3 · Cited by 91 · see citing works

Bidirectional regulation of mu‐opioid and CB1‐cannabinoid receptor in rats self‐administering heroin or WIN 55,212‐2

Fattore, L., Viganò, D., Fadda, P., Rubino, T., Fratta, W., & Parolaro, D. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05470.x · Cited by 89 · see citing works

PRECLINICAL STUDY: FULL ARTICLE: Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR‐α nuclear receptors

Luchicchi, A., Lecca, S., Carta, S., Pillolla, G., Muntoni, A. L., Yaşar, S., Goldberg, S. R., & Pistis, M. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00222.x · Cited by 86 · see citing works

Chronic treatment with Δ‐9‐tetrahydrocannabinol alters the structure of neurons in the nucleus accumbens shell and medial prefrontal cortex of rats

Kolb, B. E., Gorny, G., Limebeer, C. L., & Parker, L. A. (2006) · Synapse · doi:10.1002/syn.20313 · Cited by 84 · see citing works

Neurobiology of hedonic tone: the relationship between treatment-resistant depression, attention-deficit hyperactivity disorder, and substance abuse

Katzman, M., & Sternat, T. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s111818 · Cited by 83 · see citing works

SR141716A reduces the reinforcing properties of heroin but not heroin‐induced increases in nucleus accumbens dopamine in rats

Caillé, S., & Parsons, L. H. (2003) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2003.02961.x · Cited by 80 · see citing works

Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis

Colizzi, M., Weltens, N., McGuire, P. K., Lythgoe, D. J., Williams, S., Oudenhove, L. V., & Bhattacharyya, S. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0374-8 · Cited by 74 · see citing works

Attenuation of basal and cocaine-enhanced locomotion and nucleus accumbens dopamine in cannabinoid CB1-receptor-knockout mice

Li, X., Hoffman, A. F., Peng, X., Lupica, C. R., Gardner, E. L., & Xi, Z. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1432-0 · Cited by 74 · see citing works

Role of the endocannabinoid system in vertebrates: Emphasis on the zebrafish model

Oltrabella, F., Melgoza, A., Nguyen, B., & Guo, S. (2017) · Development Growth & Differentiation · doi:10.1111/dgd.12351 · Cited by 72 · see citing works

Cannabinoid CB1 and CB2 receptor mechanisms underlie cannabis reward and aversion in rats

Spiller, K. J., Bi, G., He, Y., Galaj, E., Gardner, E. L., & Xi, Z. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14625 · Cited by 67 · see citing works

Basic neuroanatomy and neuropharmacology of cannabinoids

Breivogel, C. S., & Sim‐Selley, L. J. (2009) · International Review of Psychiatry · doi:10.1080/09540260902782760 · Cited by 66 · see citing works

Agonism of the endocannabinoid system modulates binge-like alcohol intake in male C57BL/6J mice: involvement of the posterior ventral tegmental area

Linsenbardt, D. N., & Boehm, S. L. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.08.007 · Cited by 66 · see citing works

Cannabis induced increase in striatal glutamate associated with loss of functional corticostriatal connectivity

Mason, N. L., Theunissen, E. L., Hutten, N. R. P. W., Tse, D. H. Y., Toennes, S. W., Stiers, P. L. J., & Ramaekers, J. G. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.12.003 · Cited by 64 · see citing works

CB1 Receptor Activation on VgluT2-Expressing Glutamatergic Neurons Underlies Δ9-Tetrahydrocannabinol (Δ9-THC)-Induced Aversive Effects in Mice

Han, X., He, Y., Bi, G., Zhang, H., Song, R., Liu, Q., Egan, J. M., Gardner, E. L., Li, J., & Xi, Z. (2017) · Scientific Reports · doi:10.1038/s41598-017-12399-z · Cited by 66 · see citing works

Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders

Galaj, E., & Xi, Z. (2019) · CNS Drugs · doi:10.1007/s40263-019-00664-w · Cited by 65 · see citing works

Role of the endocannabinoid system in MDMA intracerebral self‐administration in rats

Braida, D., & Sala, M. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704825 · Cited by 63 · see citing works

A Brain on Cannabinoids: The Role of Dopamine Release in Reward Seeking and AddictionPreprint

Peters, K. Z., Oleson, E. B., & Cheer, J. F. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a039305 · Cited by 61 · see citing works

Age-varying time trends in cannabis- and alcohol-related risk perceptions 2002–2019

Waddell, J. T. (2021) · Addictive Behaviors · doi:10.1016/j.addbeh.2021.107091 · Cited by 61 · see citing works

Construction of a Polyheterocyclic Benzopyran Library with Diverse Core Skeletons through Diversity-Oriented Synthesis Pathway

Oh, S., Jang, H. J., Ko, S. K., Ko, Y., & Park, S. B. (2010) · Journal of Combinatorial Chemistry · doi:10.1021/cc100044w · Cited by 60 · see citing works

Regulation of Brain Reward by the Endocannabinoid System: A Critical Review of Behavioral Studies in Animals

Vlachou, S., & Panagis, G. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990433 · Cited by 60 · see citing works

Does cannabis affect dopaminergic signaling in the human brain? A systematic review of evidence to date.

Sami, M., Rabiner, E., & Bhattacharyya, S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.03.011 · Cited by 68 · see citing works

Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist

Justinová, Z., Ferré, S., Redhi, G. H., Mascia, P., Stroik, J., Quarta, D., Yaşar, S., Müller, C. E., Franco, R., & Goldberg, S. R. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00258.x · Cited by 59 · see citing works

Central nervous system effects of haloperidol on THC in healthy male volunteers

Liem-Moolenaar, M., Beek, E. T. T., de Kam, M. L., Franson, K. L., Kahn, R. S., Hijman, R., Touw, D. J., & van Gerven, J. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109358200 · Cited by 59 · see citing works

Role of the endocannabinoid system in brain functions relevant for schizophrenia: an overview of human challenge studies with cannabis or ∆9-tetrahydrocannabinol (THC).

Bossong, M., Jansma, J., Bhattacharyya, S., & Ramsey, N. (2014) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.11.017 · Cited by 58 · see citing works

Behavioral effects of psychostimulants in mutant mice with cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons

Canseco-Alba, A., Schanz, N., Sanabria, B., Zhao, J., Lin, Z., Liu, Q., & Onaivi, E. S. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.11.043 · Cited by 59 · see citing works

Interactions between the cannabinoid and dopaminergic systems: Evidence from animal studies

Khoury, M. E., Gorgievski, V., Moutsimilli, L., Bruno Giros, A., & Tzavara, E. T. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.12.005 · Cited by 58 · see citing works

Reduced responsiveness of the reward system is associated with tolerance to cannabis impairment in chronic users

Mason, N. L., Theunissen, E. L., Hutten, N. R. P. W., Tse, D. H. Y., Toennes, S. W., Jansen, J. F. A., Stiers, P. L. J., & Ramaekers, J. G. (2019) · Addiction Biology · doi:10.1111/adb.12870 · Cited by 58 · see citing works

Synaptic Targets of 9-Tetrahydrocannabinol in the Central Nervous SystemPreprint

Hoffman, A. F., & Lupica, C. R. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012237 · Cited by 58 · see citing works

Epigenetic and Proteomic Expression Changes Promoted by Eating Addictive-Like Behavior

Mancino, S., Burokas, A., Cuesta, J., Gutiérrez‐Martos, M., Martín‐García, E., Pucci, M., Falconi, A., D’Addario, C., Maccarrone, M., & Maldonado, R. J. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.129 · Cited by 57 · see citing works

Effects of acute systemic and intra-cerebral stimulation of cannabinoid receptors on sensorimotor gating, locomotion and spatial memory in rats

Wegener, N., Kuhnert, S., Thüns, A., Roese, R., & Koch, M. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1148-1 · Cited by 57 · see citing works

Role of γ‐Aminobutyric Acid (GABA) and Metabotropic Glutamate Receptors in Nicotine Reinforcement: Potential Pharmacotherapies for Smoking Cessation

Markou, A., Paterson, N. E., & Semenova, S. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1316.061 · Cited by 56 · see citing works

Cannabinoids as hippocampal network administrators

Lupica, C. R., Hu, Y., Devinsky, O., & Hoffman, A. F. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.003 · Cited by 55 · see citing works

Chronic Δ9-Tetrahydrocannabinol Exposure Induces a Sensitization of Dopamine D2/3 Receptors in the Mesoaccumbens and Nigrostriatal Systems

Ginovart, N., Tournier, B. B., Sallanon, M. M., Steimer, T. J., Ibanez, V., & Millet, P. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.91 · Cited by 56 · see citing works

Chronic exposure to Δ9-tetrahydrocannabinol downregulates oxytocin and oxytocin-associated neurophysin in specific brain areas

Butovsky, E., Juknat, A., Elbaz, J., Shabat-Simon, M., Eilam, R., Zangen, A., Altstein, M., & Vogel, Z. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.01.008 · Cited by 52 · see citing works

The role of the CB1 cannabinoid receptor and its endogenous ligands, anandamide and 2-arachidonoylglycerol, in amphetamine-induced behavioural sensitization

Thiemann, G., VANDERSTELT, M., Petrosino, S., Molleman, A., Marzo, V. D., & Hasenöhrl, R. U. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.09.022 · Cited by 51 · see citing works

Endocannabinoid 2-Arachidonoylglycerol Self-Administration by Sprague-Dawley Rats and Stimulation of in vivo Dopamine Transmission in the Nucleus Accumbens Shell

Luca, M. A. D., Valentini, V., Bimpisidis, Z., Cacciapaglia, F., Caboni, P., & Chiara, G. D. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00140 · Cited by 51 · see citing works

Animal models of cannabinoid reward

Panlilio, L. V., Justinová, Z., & Goldberg, S. R. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00775.x · Cited by 49 · see citing works

Marijuana's interaction with brain reward systems: Update 1991

Gardner, E. L., & Lowinson, J. H. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90365-9 · Cited by 197 · see citing works

Addictive Basis of Marijuana and Cannabinoids

Gardner, E. L. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-165-7_6

Development of an adolescent marijuana educational presentation: Preliminary findings

Cavallo, D. A., Kong, G., & Krishnan‐Sarin, S. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.02.103

Cannabinoid Interaction with Brain Reward Systems

Gardner, E. L. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-710-9_19 · Cited by 20 · see citing works

Endocannabinoid signaling system and brain reward: emphasis on dopamine

GARDNER, E. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.032 · Cited by 387 · see citing works